Capital Rx · 15 hours ago
Analyst, Client Financial Operations
Maximize your interview chances
Health CareMedical
Insider Connection @Capital Rx
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Reconcile ERP system to ensure amounts to be invoiced to clients are accurate
Utilize SQL or other data query applications to prepare journal entries, accruals, and adjustments as required
Respond to questions via email from different departments regarding client invoicing
Generate ad hoc reports as required to support client billing
Interpret client contracts for financial obligations
Implement process improvements and collaborate enhancement for data and other related revenue items
Collaborate with different departments to get needed information to bill for new programs
Ensure finance is being supplied with all information needed for revenue purposes
Responsible for adherence to the Capital Rx Code of Conduct including reporting of noncompliance
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
2+ years of related experience in finance, data analysis, or accounting
Strong Excel and SQL Skills
Ability to challenge and improve existing processes through automation and redesign
Motivated team player with the ability to work in a fast-paced, forward-moving environment
Attention to detail & commitment to delivering high quality work
Passion for healthcare and for driving lasting change in pharmacy benefits
Ability to define problems, collect data, establish facts, solve problems, make recommendations, and draw valid conclusions in a timely and accurate manner
Preferred
Undergraduate bachelor’s degree in Business, Finance, or quantitative field and/or PBM experience
Python experience
Company
Capital Rx
Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
Funding
Current Stage
Late StageTotal Funding
$252.96MKey Investors
Prime TherapeuticsB CapitalTransformation Capital
2024-03-13Corporate Round· undefined
2023-10-11Series D· $50M
2022-06-13Series C· $106M
Recent News
2024-05-20
Company data provided by crunchbase